KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Vertex Pharmaceuticals (VRTX) over the last 6 years, with Q4 2025 value amounting to $5.7 billion.

  • Vertex Pharmaceuticals' Long-Term Investments rose 1183.27% to $5.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.7 billion, marking a year-over-year increase of 1183.27%. This contributed to the annual value of $5.7 billion for FY2025, which is 1183.27% up from last year.
  • According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Long-Term Investments is $5.7 billion, which was up 1183.27% from $5.7 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Long-Term Investments ranged from a high of $5.7 billion in Q3 2025 and a low of $112.2 million during Q4 2022
  • Over the past 4 years, Vertex Pharmaceuticals' median Long-Term Investments value was $4.4 billion (recorded in 2024), while the average stood at $3.7 billion.
  • Its Long-Term Investments has fluctuated over the past 5 years, first surged by 212620.32% in 2023, then skyrocketed by 1183.27% in 2025.
  • Vertex Pharmaceuticals' Long-Term Investments (Quarter) stood at $112.2 million in 2022, then soared by 2126.2% to $2.5 billion in 2023, then soared by 104.5% to $5.1 billion in 2024, then grew by 11.83% to $5.7 billion in 2025.
  • Its last three reported values are $5.7 billion in Q4 2025, $5.7 billion for Q3 2025, and $5.6 billion during Q2 2025.